The cornea is the clear window at the front of the eye and is the eye's main refractive medium. Its transparency is essential for vision. Corneal neovascularisation is a common clinical problem with serious consequences for vision; it can compromise corneal transparency and plays a major role in corneal graft rejection by breaching corneal immune privilege. In this review, we formulate a consensus on the unmet medical needs in the management of corneal neovascularisation and outline a framework for the clinical research that is needed to identify suitable agents to meet these needs.
|Number of pages||7|
|Journal||British Journal of Ophthalmology|
|Publication status||Published - Jan 2012|
- Angiogenesis Inhibitors/therapeutic use
- Corneal Diseases/drug therapy
- Corneal Neovascularization/drug therapy
- Practice Guidelines as Topic